Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes

NCT00704275 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: 0.05% cyclosporin eye drop

Sponsor

Chulalongkorn University

Collaborators

[object Object]